Hydralazine hydrochloride 25 mg / hydrochlorothiazide 15 mg / reserpine 0.1 mg [Serathide]
RxNorm 905402
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 905402 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: hydralazine hydrochloride 25 mg / hydrochlorothiazide 15 mg / reserpine 0.1 mg [Serathide].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDC
Semantic Branded Drug Component (SBDC):
Hydralazine hydrochloride 25 mg / hydrochlorothiazide 15 mg / reserpine 0.1 mg [Serathide]
(Atom ID: 12301657)
TMSY